Objective To investigate the effects of pravastatin on the serum lipids, the tumor necrosis factor (TNF)α and the expressions of Bax and Bcl-2 in apoE-/- mouse. Methods The atherosclerosis model of apoE-/- mouse was induced by high cholesterol diet;and the suspension of pravastatin was administered intragastrieally. After 8 weeks, the levels of serum TNFα and mRNA of aortic TNFα were detected by enzyme linked immunosorbent assay (ELISA) and reverse transcription polymerase chain reaction (RT-PCR), respectively. The expressions of Bax and Bcl-2 were tested by Western blot analysis and aortic histomorphology changes was observed by Hematoxylin-Eosin (HE) stainning. Results In atherosclerosis model of apoE-/- mouse, the serum lipids, the levels of serum and aortic TNFα[(34.8±22.7) μg/L and (180.1±59.1 )μg/L], the expressions of Bax and Bcl-2 and aortic histomorphology were obviously improved by pravastatin. Conclusions It is suggested that the pravastatin can reduce serum lipid, intervene the initiation step of atherosclerosis and regulate endothelial cells' apoptosis.

Purpose To investigate the expression of DLC1 and its relationship with Ki-67 in cancerous and non-cancerous tissues of the breast.Methods In situ hybridization and immunohistochemiscal EnVision method were used to detect the expression of DLC1 mRNA and protein and Ki-67 in 52 invasive breast ductal carcinomas and 42 non-cancerous mammary tissues, including 22 mammary fibroadenomas and 20 paracancerous tissues.Results The positive rates of DLC1 mRNA and protein expression in the breast carcinomas (50% and 57.7%) was significantly lower than that in the non-cancerous mammary tissues (90.5% and 92.9%) (χ~2=17.518 and 10.729,P＜0.01).The expression of DLC1-mRNA was positively related to DLC1protein (r_s=0.379,P＜0.01). The positive rate of Ki-67 expression was 61.5% in the breast carcinomas, but no expression was observed in the all non-cancerous tissues (χ~2=39.186,P＜0.01).Correlation analysis showed that DLC1 expression was negatively correlated with Ki-67 expression (r_s=-0.507,P＜0.01).Conclusions Lower or no expression of DLC1 mRNA and protein may play an important role in the pathogenesis and progression in breast carcinoma. DLC1 may inhibit the proliferation of the breast carcinoma cells,which indicates that it may act as a new molecular marker of breast carcinoma.Combining detection of DLC1 and Ki-67 may be useful parameters for evaluating the biological behaviors of breast carcinoma.

Objective To understand the compliance of antihypertensive drug use in patients with hypertension.Methods A retrospective analysis was conducted among 218 patients with hypertension to understand their drug use compliancy and influencing factors,including side effect of the drugs,drug type,educational level,economic status and drug use length.Results The factors including disease course,drug type,drug use length and drug side effects,the economy status,educational level,awareness of hypertension related knowledge and psychological reaction could significantly influence the compliance of antihypertensive drug use.Among the patients surveyed,86.67％ of them with poor drug use compliance had only an educational level less than senior high school,77.33％ had poor awareness of hypertension related knowledge.Conclusion The antihypertensive drug use compliance in patients with hypertension is directly related to the outcome of the disease in clinical treatment.It is necessary to take effective measures to improve the treatment compliance and maintain normal blood pressure level of the patients.